The Hepatocellular Carcinoma GUIDELINES Pocket Card is based on the latest guidelines of the American Association for the Study of Liver Diseases and was developed with their collaboration. This practical quick-reference tool contains key points, surveillance and assessment recommendations, treatment recommendations, and algorithms for evaluating hepatic nodules and staging.
• Key Points
• Surveillance and Assessment Recommendations
o Role of AFP
o Investigating Small Hepatic Nodules
o The BCLC Staging System and Treatment Allocation
• Treatment Recommendations
• Current Medication Table With Brand and Generic Names
• Detailed Drug Information: Strengths, Formulations, Comments
4" x 7"
High quality paper stock
AASLD’s mission is to Advance the Science and Practice of Hepatology, Liver Transplantation and Hepatobiliary Surgery, Thereby Promoting Liver Health and Optimal Care of Patients with Liver and Biliary Tract Diseases
AASLD is the leading organization of scientists and healthcare professionals committed to preventing and curing liver disease. AASLD was founded in 1950 by a small group of leading liver specialists to bring together those who had contributed to the field of hepatology.
AASLD has grown to an international society responsible for all aspects of hepatology, and our annual meeting, The Liver Meeting®, has grown in attendance from 12 to over 7,000 physicians, surgeons, researchers, and allied health professionals from around the world.
The Digital version of the Hepatocellular Carcinoma GUIDELINES contains all the same great information found in the Pocketcard, and can be accessed on Mobile devices and online:
For a single low price: $6.99
Includes automatic updates on drugs and indications